Evidence map›Paper›PMID 19435817›Full record

ArticleMolecular cancer research : MCR2009

Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.

Davide Melisi, Jiangong Niu, Zhe Chang, Qianghua Xia, Bailu Peng, Satoshi Ishiyama, Douglas B Evans, Paul J Chiao

Open access · greenAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Davide MelisiDepartment of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Jiangong Niu
Zhe Chang
Qianghua Xia
Bailu Peng
Satoshi Ishiyama
Douglas B Evans
Paul J Chiao
The University of Texas MD Anderson Cancer Center · US

Funding

Mechanisms of RelA Activation in CancerR01CA097159 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHIAO, PAUL J · 2003 to 2013
$1.9M
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic CancerR01CA140410 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHIAO, PAUL J · 2010 to 2014
$1.6M
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer MetastasisR01CA142674 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHIAO, PAUL J · 2010 to 2014
$1.6M
Mechanisms of Tumorigenesis in Pancreatic Epithelial CellsR01CA109405 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHIAO, PAUL J · 2005 to 2009
$933k
NCI NIH HHS CA097159NCI NIH HHS CA109405NCI NIH HHS R01 CA097159NCI NIH HHS R01 CA109405NCI NIH HHS R01 CA140410NCI NIH HHS R01 CA142674
6 · The paper itself

Abstract

Transcription factor nuclear factor-kappaB (NF-kappaB) is constitutively activated in most pancreatic cancer tissues and cell lines but not in normal pancreas nor in immortalized/nontumorigenic human pancreatic ductal epithelial cells. Inhibition of constitutive NF-kappaB activation in pancreatic cancer cell lines suppresses tumorigenesis and tumor metastasis. Recently, we identified autocrine secretion of proinflammatory cytokine interleukin (IL)-1alpha as the mechanism of constitutive NF-kappaB activation in metastatic pancreatic cancer cell lines. However, the role of IL-1alpha in determining the metastatic potential of pancreatic tumor remains to be further investigated. In the current study, we stably expressed IL-1alpha in the nonmetastatic, IL-1alpha-negative MiaPaCa-2 cell lines. Our results showed that the secretion of IL-1alpha in MiaPaCa-2 cells constitutively activated NF-kappaB and increased the expression of NF-kappaB downstream genes involved in the different steps of the metastatic cascade, such as urokinase-type plasminogen activator, vascular endothelial growth factor, and IL-8. MiaPaCa-2/IL-1alpha cells showed an enhanced cell invasion in vitro compared with parental MiaPaCa-2 cells and induced liver metastasis in an orthotopic mouse model. The metastatic phenotype induced by IL-1alpha was inhibited by the expression of phosphorylation-defective IkappaB (IkappaB S32, 36A), which blocked NF-kappaB activation. Consistently, silencing the expression of IL-1alpha by short hairpin RNA in the highly metastatic L3.6pl pancreatic cancer cells completely suppressed their metastatic spread. In summary, these findings showed that IL-1alpha plays key roles in pancreatic cancer metastatic behavior through the constitutive activation of NF-kappaB. Our findings further support the possible link between inflammation and cancer and suggest that IL-1alpha may be a potential therapeutic target for treating pancreatic adenocarcinoma.

Indexed as

AnimalsBlotting, WesternCell Line, TumorCell MovementCell ProliferationElectrophoretic Mobility Shift AssayGene Expression Regulation, NeoplasticHumansInterleukin-1alphaMiceMice, Inbred BALB CMice, NudeMice, SCIDNeoplasm MetastasisNeoplasm TransplantationNF-kappa BInterleukin-1alphaNF-kappa B

Identifiers

PMID19435817
PMCPMC2856954
OpenAlexW2096159344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.